Skip to main content
Clinical Trials/ACTRN12611000120976
ACTRN12611000120976
Completed
未知

The application of Myofascial Trigger Point therapy in maintaining or increasing muscle length in muscles with spasticity, influencing the need for Botox and functional ability in School Aged Children with Spastic Cerebral Palsy (GMFCS level I-III).

Therapy ACT0 sites20 target enrollmentFebruary 2, 2011

Overview

Phase
未知
Intervention
Not specified
Conditions
Spastic Cerebral Palsy
Sponsor
Therapy ACT
Enrollment
20
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 2, 2011
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Therapy ACT

Eligibility Criteria

Inclusion Criteria

  • Children aged between 5 and 12 years
  • Cerebral Palsy GMFCS level I and III with muscle spasticity
  • Parent and Doctor consent

Exclusion Criteria

  • None required.

Outcomes

Primary Outcomes

Not specified

Similar Trials